These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16109626)

  • 1. Effect of the drug-excipient ratio in matrix-type-controlled release systems: computer simulation study.
    Villalobos R; Ganem A; Cordero S; Vidales AM; Domínguez A
    Drug Dev Ind Pharm; 2005 Jul; 31(6):535-43. PubMed ID: 16109626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo simulations for the study of drug release from cylindrical matrix systems with an inert nucleus.
    Martínez L; Villalobos R; Sánchez M; Cruz J; Ganem A; Melgoza LM
    Int J Pharm; 2009 Mar; 369(1-2):38-46. PubMed ID: 19027839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Release from Inert Spherical Matrix Systems Using Monte Carlo Simulations.
    Villalobos R; Garcia EV; Quintanar D; Young PM
    Curr Drug Deliv; 2017; 14(1):65-72. PubMed ID: 27174175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters affecting drug release from inert matrices. 1: Monte Carlo simulation.
    Villalobos R; Viquez H; Hernández B; Ganem A; Melgoza LM; Young PM
    Pharm Dev Technol; 2012; 17(3):344-52. PubMed ID: 21214424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts.
    Caraballo I; Melgoza LM; Alvarez-Fuentes J; Soriano MC; Rabasco AM
    Int J Pharm; 1999 Apr; 181(1):23-30. PubMed ID: 10370199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug particle size in ultrasound compacted tablets. Continuum percolation model approach.
    Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 310(1-2):168-74. PubMed ID: 16431046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the drug/excipient particle size ratio in the percolation model for tablets.
    Millán M; Caraballo I; Rabasco AM
    Pharm Res; 1998 Feb; 15(2):216-20. PubMed ID: 9523306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percolation thresholds in ultrasound compacted tablets.
    Caraballo I; Millán M; Fini A; Rodriguez L; Cavallari C
    J Control Release; 2000 Dec; 69(3):345-55. PubMed ID: 11102675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new biodegradable polythiourethane as controlled release matrix polymer.
    Campiñez MD; Ferris C; de Paz MV; Aguilar-de-Leyva A; Galbis J; Caraballo I
    Int J Pharm; 2015 Mar; 480(1-2):63-72. PubMed ID: 25579868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit disodium [correction of dissodium] salt in controlled release matrices.
    Boza A; Blanquero R; Millan M; Caraballo I
    Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):797-801. PubMed ID: 15256698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release behaviour of clozapine matrix pellets based on percolation theory.
    Aguilar-de-Leyva A; Sharkawi T; Bataille B; Baylac G; Caraballo I
    Int J Pharm; 2011 Feb; 404(1-2):133-41. PubMed ID: 21094234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the percolation thresholds in dextromethorphan hydrobromide matrices.
    Melgoza LM; Rabasco AM; Sandoval H; Caraballo I
    Eur J Pharm Sci; 2001 Feb; 12(4):453-9. PubMed ID: 11231112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between compactibility values and excipient cluster size using an in silico approach.
    Martínez L; Betz G; Villalobos R; Melgoza L; Young PM
    Drug Dev Ind Pharm; 2013 Feb; 39(2):374-81. PubMed ID: 22568747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics.
    Bonny JD; Leuenberger H
    Pharm Acta Helv; 1991; 66(5-6):160-4. PubMed ID: 1784581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.